Quadrature Capital LTD Immunic, Inc. Transaction History
Quadrature Capital LTD
- $4.51 Trillion
- Q1 2025
A detailed history of Quadrature Capital LTD transactions in Immunic, Inc. stock. As of the latest transaction made, Quadrature Capital LTD holds 44,536 shares of IMUX stock, worth $38,746. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,536Holding current value
$38,746% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMUX
# of Institutions
71Shares Held
47.2MCall Options Held
1.14MPut Options Held
130K-
Bvf Inc San Francisco, CA8.9MShares$7.75 Million0.43% of portfolio
-
Abrdn PLC8.24MShares$7.17 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$6.34 Million0.66% of portfolio
-
Avidity Partners Management LP Dallas, TX4.45MShares$3.88 Million1.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.13MShares$3.59 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $26.6M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...